- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00949195
Pulmonary Arterial Pressure Response During Exercise (PAPCOPDHS)
Pulmonary Arterial Pressure Response During Exercise in COPD and Healthy Subjects
Background:
The extent of increase in systolic pulmonary arterial pressure (PAPs) during exercise in patients with COPD is unpredictable from lung function data. The non-invasive assessment of pulmonary hemodynamics during exercise and flow-mediated vasodilatation measurement may give useful data in the rehabilitation of COPD patients.
Methods:
Patients with stable, severe COPD and healthy, age-matched subjects (H) perform semi supine echocardiography with PAPs measurement. COPD patients perform ramp protocol with gas exchange detection. Serum hsCRP level is also determined in COPD patients. Endothel dysfunction is detected by flow mediated vasodilation measurement after arm strangulation with Doppler ultrasonography.
Primary endpoint:
The degree of pulmonary artery systolic pressure change during exercise?
Secondary endpoint:
- The degree of right ventricular function change during exercise?
- Is endothel dysfunction manifested with pulmonary artery pressure rise?
- What is the correlation between the systemic inflammatory marker hsCRP and the degree of pulmonary artery pressure rise?
Study Overview
Status
Conditions
Detailed Description
Background: The extent of increase in systolic pulmonary arterial pressure (PAPs) during exercise in patients with COPD is unpredictable from lung function data. The non-invasive assessment of pulmonary hemodynamics during exercise by semi-supine echocardiography and flow-mediated vasodilatation measurement may give useful data in the rehabilitation of COPD patients.
Methods: Patients with stable, severe COPD and healthy, age-matched subjects (H) perform semi supine echocardiography with PAPs measurement. COPD patients perform ramp protocol with gas exchange detection. Serum hsCRP level is also determined in COPD patients. All of the subjects perform complete lung function with body pletysmography and diffusion capacity measurement. Endothel dysfunction is detected by flow mediated vasodilation measurement after arm strangulation with Doppler ultrasonography.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Attila Somfay, MD, PhD
- Phone Number: +36-62-571-551
- Email: somfay@deszk.szote.u-szeged.hu
Study Contact Backup
- Name: Janos Varga, MD
- Phone Number: +36-62-571-527, +36209204235
- Email: janosvargaster@gmail.com
Study Locations
-
-
Csongrad County
-
Deszk, Csongrad County, Hungary, 6772
- Recruiting
- Department of Pulmonology, Szeged University
-
Contact:
- Janos Varga, MD
- Phone Number: +36-62-571-527, +36209204235
- Email: janosvargaster@gmail.com
-
Contact:
- Attila Somfay, MD, PhD
- Phone Number: +36-62-571-552
- Email: somfay@deszk.szote.u-szeged.hu
-
Principal Investigator:
- Attila Somfay, MD, PhD
-
Sub-Investigator:
- Janos Varga, MD
-
Sub-Investigator:
- Imre Lajko, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- COPD patients (age between 45 and 70)
- with moderate to severe obstruction (FEV1<60%pred) and
- healthy subjects (age between 45 and 70, (FEV1>80%pred, FEV1/FVC>70%
Exclusion Criteria:
- Not in the age range
- Different FEV1 value
- Severe comorbidities
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
COPD patients
COPD patients with severe obstruction performed the tests.
|
Semi-supine echocardiography test
Other Names:
Semi-supine echocardiography test
Other Names:
|
Healthy subjects
Age-matched healthy subjects performed the same test also.
|
Semi-supine echocardiography test
Other Names:
Semi-supine echocardiography test
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The degree of pulmonary artery pressure change during exercise?
Time Frame: 2 months
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Right ventricular function change? Correlation between systemic inflammation (hsCRP) and pulmonary artery pressure change? Endothelial dysfunction?
Time Frame: 2 months
|
2 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Attila Somfay, MD, PhD, Department of Pulmonology, Szeged University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SZTE PULM-PAHP
- ISRCTN11034505
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
PfizerRecruitingHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Shouyao Holdings (Beijing) Co. LTDNot yet recruiting
-
Abbisko Therapeutics Co, LtdNot yet recruiting
-
Vigonvita Life SciencesRecruiting
Clinical Trials on Measure pulmonary artery pressure change during exercise
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Northwestern UniversityGE HealthcareCompleted
-
Bicetre HospitalRecruitingARDS, Human | Ventilation Therapy; Complications | Alveolar; DisorderFrance
-
IHF GmbH - Institut für HerzinfarktforschungRecruiting
-
French Cardiology SocietyFrench Federation of CardiologyCompletedHeart Failure With Preserved Ejection Fraction (HFPEF) | Left Ventricular End Diastolic Pressure (LVEDP)France
-
University Hospital, GenevaActive, not recruitingCoronary Artery Disease | Mitral Regurgitation | Mitral Valve Insufficiency | Coronary StenosisSwitzerland
-
Medical University of GrazEuropean Respiratory SocietyRecruitingPulmonary Circulation DiseasesUnited States, Italy, United Kingdom, Austria, Australia, Belgium, Brazil, Denmark, France, Germany, Netherlands, Poland, Spain, Switzerland
-
Inova Health Care ServicesAbbottRecruitingHeart Failure | Cardiogenic Shock | Ambulatory Hemodynamic MonitoringUnited States
-
University Hospital, ToulouseUnknownChoroid Disease | Hypertension OcularFrance
-
Institute for Clinical and Experimental MedicineNot yet recruitingHeart Failure | Pulmonary Hypertension | Pulmonary Vascular Resistance AbnormalityCzechia